Lynette M. Brown

Lynette M. Brown, MD, PhD

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine

Divisions: Public Health

Academic Office Information

u0648367@utah.edu

Education History

Fellowship Johns Hopkins School of Medicine
 Fellow
Johns Hopkins School of Medicine
 Resident
Professional Medical Johns Hopkins School of Medicine
 MD
University of Kansas
 Postdoctoral Fellow
Doctoral Training University of Oklahoma Health Sciences Center
 PhD
University of Oklahoma
 BS

Selected Publications

Journal Article

  1. Cirulis MM, Knox DB, Stoddard GJ, Brown LM, Elliott CG, Brown SM, Dodson MW (2022). The CTEPH Trajectories Study: Assessment of Follow-up after Acute Pulmonary Embolism to Identify Missed Opportunities for CTEPH Diagnosis. Ann Am Thorac Soc, 19, 1428-1432. (Read full article)
  2. Dodson MW, Cirulis MM, Li H, Yue Z, Brown LM, Elliott CG (2022). Frequency of Thrombotic Risk Factors in Patients with Chronic Thromboembolic Pulmonary Hypertension and Acute Pulmonary Embolism: A Case-Control Study. Clin Appl Thromb Hemost, 28, 10760296211073277. (Read full article)
  3. Cirulis MM, Dodson MW, Brown LM, Brown SM, Lahm T, Elliott G (2020). At the X-Roads of Sex and Genetics in Pulmonary Arterial Hypertension. Genes (Basel), 11(11). (Read full article)
  4. Dodson MW, Allen-Brady K, Brown LM, Elliott CG, Cannon-Albright LA (2018). Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families. Chest, 155(2), 384-390. (Read full article)
  5. Best DH, Sumner KL, Smith BP, Damjanovich-Colmenares K, Nakayama I, Brown LM, Ha Y, Paul E, Morris A, Jama MA, Dodson MW, Bayrak-Toydemir P, Elliott CG (2016). EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension. Chest, 151(4), 821-828. (Read full article)
  6. Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG (2013). EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest, 145(2), 231-236. (Read full article)
  7. Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG (Winter 2013). EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis. Chest, 145, 231-236.
  8. Adams DM, Stevens SM, Woller SC, Evans RS, Lloyd JF, Snow GL, Allen TL, Bledsoe JR, Brown LM, Blagev DP, Lovelace TD, Shill TL, Conner KE, Aston VT, Elliott CG (2013). Adherence to PIOPED II investigators' recommendations for computed tomography pulmonary angiography. Am J Med, 126(1), 36-42. (Read full article)
  9. Brown LB and Elliott CG (2012). Time to diagnosis of pulmonary arterial hypertension. Adv Pulm Hypertens, 11(2), 69-72.
  10. Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG (2011). Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest, 140(1), 19-26. (Read full article)
  11. Elliott CG, Barst RJ, Seeger W, Porres-Aguilar M, Brown LM, Zamanian RT, Rubin LJ (2010). Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest, 137(6 Suppl), 85S-94S. (Read full article)
  12. Magarian RA, Avor K, Overacre LB, Kunchandy J, Paxton TR (1995). Synthesis and Biological Evaluation of Side Chain Derivatives of Analog II as Pure Antiestrogens and Antitumor Agents. Anticancer Drug Des, 10, 311-331.
  13. Hossain MB, van der Helm D, Schmitz FJ, Podesimo EO, Magarian RA, Meyer KL, Overacre LB, Day BW (1994). Molecular Structures and Conformational Studies of Triarylcyclopropol and Related Antiestrogens. J Med Chem, 37, 1670-1683.

Letter

  1. Dodson MW, Sumner K, Carlsen J, Cirulis MM, Wilson EL, Gadre A, Fernandes TM, Brown LM, Best DH, Elliott CG (2020). The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension. [Letter to the editor]. Eur Respir J, 56(4). (Read full article)

Patent

  1. LM Overacre, RA Magarian (1997). Estrogen Receptor Blockers. U.S. Patent No. 5,658,951. Washington, D.C.:U.S. Patent and Trademark Office.
  2. LM Overavce, RA Magarian (1997). Estrogen Receptor Blockers. U.S. Patent No. 5,658,927. Washington, D.C.:U.S. Patent and Trademark Office.
  3. LM Overacre, RA Magarian (1997). Estrogen Receptor Blockers. U.S. Patent No. 5,658,917. Washington, D.C.:U.S. Patent and Trademark Office.